Vicapsys Life Sciences, Inc.

OTC:VICP

2 (USD) • At close November 9, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42010 Q22010 Q12009 Q42009 Q22009 Q1
Revenue 0000000000000000000002.9260.7390.0081.0231.673
Cost of Revenue 00000.0080.0080.0080.0080.0080.0080.0080.0080000000003.1590.9330.0071.0021.531
Gross Profit 0000-0.008-0.008-0.008-0.008-0.008-0.008-0.008-0.008000000000-0.234-0.1940.0010.0210.142
Gross Profit Ratio 000000000000000000000-0.08-0.2630.070.0210.085
Reseach & Development Expenses 00.0030.0020.0100.00300.010.0100.0050.0020.008000.094-00.09900000000
General & Administrative Expenses 0.5270.1720.1340.2010.1520.1420.180.1570.0930.1110.0670.0470.0720.0890.2320.270.250.370.1510.1640.0431.0790.3820.0020.4510.366
Selling & Marketing Expenses 00.0690000000000000000000.0410.0160.00800.0260.045
SG&A 0.5270.1720.1340.2010.1520.1420.180.1570.0930.1110.0670.0470.0720.0890.2320.270.250.370.1510.1640.0841.0950.390.0020.4770.41
Other Expenses 00.0690.0670.0640.4630000.0920.02300.023286.3270.060.0940.099000000.0460.03900.0320.021
Operating Expenses 0.5270.1750.1360.2110.1520.1450.180.1670.1040.1110.0720.050.0810.0890.2320.3640.250.4690.1510.1640.0841.1420.430.0020.5080.431
Operating Income -0.527-0.175-0.136-0.211-0.493-0.145-0.18-0.167-0.104-0.111-0.072-0.05-0.081-0.089-0.232-0.364-0.25-0.469-0.151-0.164-0.084-1.375-0.624-0.002-0.487-0.289
Operating Income Ratio 000000000000000000000-0.47-0.844-0.196-0.476-0.173
Total Other Income Expenses Net -0.068-0.0650000000000.10000000000.979-0.039-0-0.044-0.028
Income Before Tax -0.595-0.24-0.136-0.211-0.493-0.145-0.18-0.167-0.104-0.111-0.0720.05-0.081-0.089-0.232-0.364-0.25-0.469-0.151-0.164-0.084-0.396-0.662-0.002-0.53-0.317
Income Before Tax Ratio 000000000000000000000-0.135-0.897-0.215-0.518-0.189
Income Tax Expense 0-0.015-0-00.34-0000.2-0-0-0.20000000.0970.2790-1.0580.0390-0.002-0.001
Net Income -0.595-0.24-0.136-0.211-0.833-0.145-0.18-0.167-0.104-0.111-0.0720.05-0.081-0.089-0.232-0.364-0.25-0.469-0.248-0.443-0.084-0.347-0.662-0.002-0.53-0.317
Net Income Ratio 000000000000000000000-0.119-0.897-0.233-0.518-0.189
EPS -0.019-0.007-0.004-0.006-0.027-0.005-0.006-0.006-0.006-0.006-0.0040.003-0.005-0.005-0.013-0.021-0.014-0.039-0.025-0.046-0.009-1.02-1.91-0.005-1.53-0.91
EPS Diluted -0.019-0.007-0.004-0.006-0.027-0.005-0.006-0.006-0.006-0.006-0.0040.002-0.005-0.005-0.013-0.021-0.014-0.039-0.025-0.046-0.009-1.02-1.91-0.005-1.53-0.91
EBITDA -0.585-0.175-0.136-0.211-0.145-0.137-0.172-0.159-0.096-0.103-0.064-0.042-0.073-0.081-0.224-0.357-0.244-0.459-0.143-0.156-0.079-0.324-0.595-0.001-0.457-0.256
EBITDA Ratio 000000000000000000000-0.456-0.805-0.191-0.447-0.153